This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Movers Roundup: OfficeMax, Biovail

Among the stock activity stories for Monday, Sept. 14, from AP Financial News:

NEW YORK (AP) ¿ Shares of office-supply retailer OfficeMax Inc. declined after a Goldman Sachs analyst said the office-supply retailer's shares are fairly valued.

NEW YORK (AP) ¿ Shares of drug developer Biovail Corp. rose as a Credit Suisse analyst upgraded shares of the stock, citing a recent string of financial deals, tax advantages, and secure patents.

HARTFORD, Conn. (AP) ¿ Shares of KBR fell after the engineering and construction company announced it was awarded an energy project worth 2.7 billion Australian dollars ($2.33 billion).

NEW YORK (AP) ¿ Shares of GFI Group Inc. slid after an analyst downgraded the stock to "neutral" from "buy," saying its shares are overpriced.

NEW YORK (AP) ¿ Shares of Blockbuster Inc. surged after an analyst said the video rental company's decision to issue $340 million of senior notes should put to rest investor concerns about liquidity.

SEATTLE (AP) ¿ Shares of chip maker Zoran Corp. jumped after an analyst said Wall Street has not taken into account how upcoming digital TV, digital camera and DVD player product launches will boost Zoran's business.

NEW YORK (AP) ¿ Shares of Emulex Corp. rose after Canaccord Adams upgraded shares on improving demand in the high-end server market.
Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
OMX $15.26 -0.26%
ELX $7.99 0.00%
GFIG $6.01 0.00%
AAPL $112.12 0.00%
FB $93.24 0.00%


Chart of I:DJI
DOW 17,084.49 +33.74 0.20%
S&P 500 2,014.89 +15.91 0.80%
NASDAQ 4,830.47 +19.6820 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs